Back
Day Range
$3.85
$16.45
52-Week Range
$3.85
$16.45
Volume
1,000
50D / 200D Avg
$16.45
/
$15.24
Prev Close
$16.45
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.3 | 0.4 |
| P/B | 0.1 | 2.9 |
| ROE % | -50.0 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
-$51.98
-$211.52 – $7.55
|
8.8 B | 1 |
| FY2029 |
$150.73
-$21.90 – $613.42
|
43 B | 1 |
| FY2028 |
$59.40
-$8.63 – $241.75
|
23 B | 1 |
Key Takeaways
Debt/Equity of 0.09 — conservative balance sheet
Negative free cash flow of -3.84B
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-50.01%
ROIC-19.17%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.09
Current Ratio28.99
Interest Coverage-46.81
Valuation
P/E Ratio
-0.33
P/B Ratio0.09
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -3.84B |
| ROE | -50.01% | ROA | -24.60% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -3.84B |
| ROIC | -19.17% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.09 | Current Ratio | 28.99 |
| Interest Coverage | -46.81 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -0.33 | P/B Ratio | 0.09 |
| P/S Ratio | N/A | PEG Ratio | -1.88 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.28B | Enterprise Value | -12.56B |
Income Statement
Annual, most recent first
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -3.84B | -2.88B | -2.64B | -5.56B | -4.68B |
| EPS (Diluted) | -52.63 | -41.85 | -40.48 | -95.99 | -90.33 |
| Gross Profit | -8.05M | 0.0 | -14.50M | -24.62M | -132.47M |
| Operating Income | -3.79B | -3.52B | -4.54B | -7.90B | -6.62B |
Balance Sheet
Annual, most recent first
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Total Assets | 15.62B | 3.45B | 5.05B | 7.05B | 5.51B |
| Total Liabilities | 2.02B | 1.68B | 2.25B | 2.62B | 3.48B |
| Shareholders' Equity | 13.60B | 1.76B | 2.79B | 4.43B | 2.04B |
| Total Debt | 1.24B | 397.00M | 665.00M | 933.00M | 2.53B |
| Cash & Equivalents | 15.08B | 2.92B | 4.45B | 6.73B | 4.56B |
| Current Assets | 15.49B | 3.34B | 4.94B | 6.97B | 5.35B |
| Current Liabilities | 534.23M | 732.08M | 905.64M | 1.09B | 1.46B |